Neurodegenerative Disorder-Targeting Compound 1
Modify Date: 2025-08-24 23:21:05
Neurodegenerative Disorder-Targeting Compound 1 structure
|
Common Name | Neurodegenerative Disorder-Targeting Compound 1 | ||
|---|---|---|---|---|
| CAS Number | 1254699-12-1 | Molecular Weight | 484.55 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H28N4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Neurodegenerative Disorder-Targeting Compound 1Neurodegenerative Disorder-Targeting Compound 1 is a carboxamide compound, used in the research of neurodegenerative disorders. |
| Name | Neurodegenerative Disorder-Targeting Compound 1 |
|---|
| Description | Neurodegenerative Disorder-Targeting Compound 1 is a carboxamide compound, used in the research of neurodegenerative disorders. |
|---|---|
| Related Catalog | |
| In Vitro | Neurodegenerative Disorder-Targeting Compound 1 can be used in the research of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease[1]. |
| References |
[1]. MACK, Helmut., et al. CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS. WO 2010128102 A1. |
| Molecular Formula | C28H28N4O4 |
|---|---|
| Molecular Weight | 484.55 |